{"disease":{"id":"mite-allergy","name":"mite allergy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04969653","title":"The Incidence of Venous Thromboembolism in Atopic Dermatitis","phase":"","overall_status":"COMPLETED","enrollment_count":754745,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT02443805","title":"Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1607,"lead_sponsor_name":"Stallergenes Greer","has_results":true},{"nct_id":"NCT04435678","title":"Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens","phase":"NA","overall_status":"COMPLETED","enrollment_count":839,"lead_sponsor_name":"MacroArray Diagnostics GmbH","has_results":false},{"nct_id":"NCT06920771","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":552,"lead_sponsor_name":"HAL Allergy","has_results":false},{"nct_id":"NCT07427576","title":"Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT06803953","title":"Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Hippocreates","has_results":false},{"nct_id":"NCT05525650","title":"Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":54,"lead_sponsor_name":"RAPHAS","has_results":false},{"nct_id":"NCT04477382","title":"Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Ecarf Institute GmbH","has_results":false},{"nct_id":"NCT03094845","title":"Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"ASIT Biotech S.A.","has_results":false},{"nct_id":"NCT04872868","title":"Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Ecarf Institute GmbH","has_results":false},{"nct_id":"NCT05019209","title":"Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Fraunhofer-Institute of Toxicology and Experimental Medicine","has_results":false},{"nct_id":"NCT04874714","title":"Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT04915352","title":"Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}